ACCELERON PHARMA INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ACCELERON PHARMA INC has filed 808 SEC EDGAR filings since 17 Feb 2004

SEC filing history

Showing 426-450 of 799 matching filings.

Per page
25
Current page
18
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
29 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
25 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87630

ACCELERON PHARMA INC.

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87630

SCHEDULE 13G (AMENDMENT NO. 2)

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87630

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87630

XLRN AS OF 12/31/2015

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87630

SC 13G/A filing

Filing date
25 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2016
Reporting date
11 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87630

AMENDMENT NO. 4 TO SCHEDULE 13D

Filing date
11 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36065

8-K

Filing date
11 Jan 2016
Reporting date
05 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-208845

424B5

Filing date
06 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-208845

424B5

Filing date
04 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-208845

S-3ASR

Filing date
04 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Dec 2015
Reporting date
22 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .